Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2
Authors
Keywords
LAT1, Tumoral blood flow, Small-animal PET, C6 glioma, MIA PaCa-2
Journal
ANNALS OF NUCLEAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-01
DOI
10.1007/s12149-019-01346-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET
- (2017) Keishi Horiguchi et al. EJNMMI Research
- Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: 18F-fluoromisonidazole and 15O-labelled gases inhalation PET
- (2017) Tadashi Watabe et al. EJNMMI Research
- Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging
- (2016) Ling Wei et al. CANCER SCIENCE
- 18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET
- (2016) Tadashi Watabe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model
- (2014) Kohei Hanaoka et al. EJNMMI Research
- The SLC3 and SLC7 families of amino acid transporters
- (2013) Dimitrios Fotiadis et al. MOLECULAR ASPECTS OF MEDICINE
- Transport of 3-Fluoro-L- -Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET
- (2012) P. Wiriyasermkul et al. JOURNAL OF NUCLEAR MEDICINE
- Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With ^|^alpha;-Alkyl Moieties
- (2012) Narakorn Khunweeraphong et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis
- (2011) Mio Furuya et al. CANCER SCIENCE
- Solute Carrier Transporters as Targets for Drug Delivery and Pharmacological Intervention for Chemotherapy
- (2011) Takeo Nakanishi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
- (2009) Koji Oda et al. CANCER SCIENCE
- Performance Evaluation of the Inveon Dedicated PET Preclinical Tomograph Based on the NEMA NU-4 Standards
- (2009) Q. Bao et al. JOURNAL OF NUCLEAR MEDICINE
- The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
- (2008) M Lo et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
- (2008) K Kaira et al. BRITISH JOURNAL OF CANCER
- l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms
- (2008) Kyoichi Kaira et al. CANCER SCIENCE
- L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
- (2008) Takeshi Sakata et al. PATHOLOGY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search